Coronavirus - we're here to help
From how to access your account online, scam awareness, your wellbeing and our community we're here to help.

Skip to main content
  • Register
  • Help
  • Contact us
  • Log out of your HL account

Fusion Antibodies Ltd (FAB) ORD GBP0.04

Sell:97.00p Buy:107.00p 0 Change: No change
Market closed Prices as at close on 3 July 2020 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:97.00p
Buy:107.00p
Change: No change
Market closed Prices as at close on 3 July 2020 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:97.00p
Buy:107.00p
Change: No change
Market closed Prices as at close on 3 July 2020 Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Fusion Antibodies PLC, formerly Fusion Antibodies, Ltd., is a United Kingdom-based cancer therapeutics developer. The Company develops and commercializes antibody-based therapeutics for cancer. The Company develops a range of antibody engineering services based around monoclonal antibodies. It focuses in the expression and purification of recombinant proteins and chimeric antibodies for the research, diagnostic and therapeutic markets. Its technology generates target specific antibodies from protein antigens. The Company's therapeutic and diagnostic research and development are offered as a service to pharmaceutical, biopharmaceutical and academic researchers.

Contact details

Address:
Springbank Industrial Estate
1 Springbank Road
BELFAST
BT17 0QL
United Kingdom
Telephone:
+44 (028) 90432800
Website:
https://fusionantibodies.com/

Important dates

Future events
There are no future events available.
Past events
General meeting 15 May 2020 15/05/20
Trading Announcement 28 April 2020 28/04/20
Trading Announcement 30 March 2020 30/03/20
Trading Announcement 29 January 2020 29/01/20
Interim results 02 December 2019 02/12/19
Trading Announcement 22 October 2019 22/10/19
AGM 20 September 2019 20/09/19
Annual report 21 August 2019 21/08/19

General stock information

EPIC:
FAB
ISIN:
GB00BDQZGK16
Market cap:
£25.93 million
Shares in issue:
25.42 million
Sector:
Health Care Equipment & Services
Exchange:
London Stock Exchange
Currency:
Sterling pence
Indices:
n/a

Key personnel

  • John Ivan George Cadogan
    Chairman of the Board
  • Simon Douglas
    CEO, Board Member
  • James Johnston
    Chief Scientific Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by NBTrader.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.